ImmuCell Corporation (ICCC) Shareholders’ equity 2017–2025
ImmuCell Corporation (ICCC) shareholders’ equity at each fiscal year-end, per SEC filings.
$27.1MFY2025 · since FY2017: $23.6M → $27.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $27.1M | -1.7% |
| FY2024 | $27.5M | +10.1% |
| FY2023 | $25.0M | -17.7% |
| FY2022 | $30.4M | -6.7% |
| FY2021 | $32.6M | +15.3% |
| FY2020 | $28.3M | -2.5% |
| FY2019 | $29.0M | +33.3% |
| FY2018 | $21.7M | -7.8% |
| FY2017 | $23.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice